Research output per year
Research output per year
Fingerprint
Dive into the research topics where Lukas Weiss is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research output
-
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial
Rinnerthaler, G. (First author), Egle, D., Bartsch, R., Schmitt, C. A., Petzer, A., Balic, M., Petru, E., Denison, U., Singer, C. F., Bjelic-Radisic, V., Gampenrieder, S. P. (Co-author), Knauer, M., Sotlar, K. (Co-author), Brunner, C. (Co-author), Posch, F., Hlauschek, D., Sölkner, L., Bago-Horvath, Z., Filipits, M. & Gili, M. & 10 others, , 16 Jan 2025, In: NATURE CANCER. 13 p.Research output: Contribution to journal › Original Article › peer-review
Open Access -
Combined DNA Analysis from Stool and Blood Samples Improves Tumor Tracking and Assessment of Clonal Heterogeneity in Localized Rectal Cancer Patients
Parigger, T., Gassner, F. J. (Co-author), Drothler, S., Scherhaeufl, C., Hoedlmoser, A., Schultheis, L., Abu Bakar, A., Huemer, F. (Co-author), Greil, R. (Co-author), Geisberger, R. (Co-author), Weiss, L. (Last author) & Zaborsky, N. (Last author), 2024, In: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 23, 12 p., 15330338241252706.Research output: Contribution to journal › Original Article › peer-review
Open Access -
Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma
Huemer, F. (First author), Weiss, L. (Co-author), Regitnig, P., Winder, T., Schmitt, C. A., Thaler, J., Wöll, E. & Greil, R. (Last author), Apr 2024, In: ESMO OPEN. 9, 4, p. 102973 2 p., 102973.Research output: Contribution to journal › Letter to the editor › peer-review
Open Access -
Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy
Lafarge, M. W., Domingo, E., Sirinukunwattana, K., Wood, R., Samuel, L., Murray, G., Richman, S. D., Blake, A., Sebag-Montefiore, D., Gollins, S., Klieser, E. (Co-author), Neureiter, D. (Co-author), Huemer, F. (Co-author), Greil, R. (Co-author), Dunne, P., Quirke, P., Weiss, L. (Co-author), Rittscher, J., Maughan, T. & Koelzer, V. H., 9 Apr 2024, In: NPJ precision oncology. 8, 1, p. 89 11 p., 89.Research output: Contribution to journal › Original Article › peer-review
Open Access -
mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214)
Hofheinz, R.-D., Herrle, F., Dechow, T., von Weikersthal, L. F., Welslau, M., Lettmaier, S., Burkart, C., Kubicka, S., Kochen, L., Merx, K., Krause, K., Ebert, M., Rödel, C., Fokas, E., Ghadimi, M., Reissfelder, C., Gaiser, T. & Weiss, L. (Study group member), Sept 2024, In: ESMO OPEN. 9, 9, p. 103703Research output: Contribution to journal › Original Article › peer-review
Open Access
Projects
- 6 Finished
-
Clinical Impact of Consensus Molecular Subtypes in Stage III Rectal Cancer
Huemer, F. (PI) & Weiss, L. (CoPI)
1/11/17 → 1/11/18
Project: Research
-
Clonal & Immunologic Evolution of Metastatic Colorectal Cancer During Neoadjuvant Chemoimmunotherapy
Weiss, L. (PI) & Huemer, F. (CoPI)
1/10/17 → 1/10/19
Project: Research
-
Analysis of circulating cell-free DNA to monitor tumor burden and treatment in head and neck cancer
Gampenrieder, S. P. (Further contributor), Hufnagl, C. (PI), Melchardt, T. (Further contributor), Magnes, T. (Further contributor), Rinnerthaler, G. (Further contributor), Egle, A. (Further contributor), Leisch, M. (Further contributor), Weiss, L. (Further contributor) & Greil, R. (Further contributor)
1/04/17 → 1/04/18
Project: Research
-
The Effect of Neoadjuvant Chemoimmunotherapy on Tumor Infiltrating Lymphocytes (TILs) in Liver Metastases in Colorectal Cancer
Huemer, F. (PI) & Weiss, L. (Further contributor)
1/08/16 → 1/08/17
Project: Research
-
The Effect of Chemoradiotherapy on Tumor Infiltrating Lymphocytes (TILs) and Prognostic Impact of TIL & TIL-Dynamics in Rectal Cancer
Huemer, F. (PI) & Weiss, L. (Further contributor)
1/03/16 → 1/03/17
Project: Research